Patents
Patents for C07D 233 - Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings (34,408)
08/2008
08/28/2008US20080207696 Phenacyl 2-Hydroxy-3-Diaminoalkanes
08/28/2008US20080207636 Using a benzmide compound; antidiabetic agents; obesity
08/28/2008US20080207589 Cyclized derivatives as eg-5 inhibitors
08/28/2008US20080206138 For example, 18F-etomidate (18F-FETO); adrenal scintigraphy and diagnosis of associated disease; radionuclide therapy of adrenocortical or extraadrenal cancer
08/28/2008CA2678958A1 Heterocyclic aspartyl protease inhibitors
08/28/2008CA2678304A1 Antibodies and pharmaceutical compositions containing same useful for inhibiting activity of metalloproteins
08/28/2008CA2678200A1 Methods for modulating bone formation and mineralization
08/27/2008EP1961744A1 Basic group-containing compound and use thereof
08/27/2008EP1961416A1 Medical use of inhibitors of glutaminyl and glutamate cyclases
08/27/2008EP1960369A1 Indanyl-and tetrahydronaphthyl-amino-azoline compounds for combating animal pests
08/27/2008EP1960368A1 2,4,5-triphenyl imidazoline derivatives as inhibitors of the interaction between p53 and mdm2 proteins for use as anticancer agents
08/27/2008EP1960352A1 2-adamantylurea derivatives as selective 11beta-hsd1 inhibitors
08/27/2008EP1959946A2 Methods of treating ischemic related conditions
08/27/2008EP1959944A1 A pharmaceutical composition comprising an amide derivative
08/27/2008EP1905763A4 N-acylic aminoacid derivatives. method for the production thereof, pharmacological composition and the use in the form of anti-allergic, anti-inflammatory and hypolipidemic agents
08/27/2008CN101253185A Transition metal complex compound and organic electroluminescent device using same
08/27/2008CN101253167A Substituted imidazole compounds as KSP inhibitors
08/27/2008CN101253156A 1,3-diiodohydantoin compound and process for production thereof
08/27/2008CN101253147A Organic compounds
08/27/2008CN101250161A 3-oxo imidazole compounds and method for synthesizing same
08/27/2008CN101250160A Chloride 1,3-di(2-hydroxy ethyl) imidazole ionic liquid and method for synthesizing same
08/27/2008CN101250159A Chloride 1,3-di(2-methoxy-2-yloxyethyl) imidazole ionic liquid and method for synthesizing same
08/27/2008CN100413873C Ion type liquid
08/27/2008CN100413853C Synthetic intermediate of Irbesartan, preparation method and use thereof
08/26/2008US7417152 4-Bromo-5-(2-chloro-benzoylamino)-1H-pyrazole-3-carboxylic acid (2-pyrrolidin-1-yl-ethyl)-amide; 5-(2-chlorobenzoylamino)-1H-pyrazole-3-carboxylic acid {2-[4-(4,5-dihydro-1H-imidazol-2-yl)-phenyl]ethyl}amide; useful for the moderation of pain, septic shock, and scarring
08/26/2008US7417151 Boron-based organic cations and related methods
08/26/2008US7417057 insecticides; safe for crops; Fused partially unsaturated carbocyclic or heterocyclic ring substituted with a 5-or 6-membered heterocyclic ring such as imidazole, thiazole, oxazole, 1,3,4-oxadiazole
08/21/2008WO2008101197A1 Catalysts containing n-heterocyclic carbenes for enantioselective synthesis
08/21/2008WO2008100577A1 Production of ionic liquids
08/21/2008WO2008100569A1 Reformation of ionic liquids
08/21/2008WO2008100480A1 Functionally selective alpha2c adrenoreceptor agonists
08/21/2008WO2008098886A2 Method for producing (meth)acrylates of n-hydroxyalkylated imidazoles
08/21/2008WO2008098798A1 Tetrahydronaphthalenylamides, a process for their production and their use as anti-inflammatory agents
08/21/2008WO2008064318A3 Peripheral opioid receptor active compounds
08/21/2008US20080200692 Process For the Synthesis of Organic Compounds
08/21/2008US20080200691 Process For the Synthesis of Organic Compounds
08/21/2008US20080200690 Preparation of 2-Substituted 4-Chloro-5-Formylimidazole and 5-Formylimidazole
08/21/2008US20080200689 Dehalogenation; reduction; nitration; rearrangement
08/21/2008US20080200551 Flourene Derivative
08/21/2008US20080200518 insecticides, acaricides; crops, foods and goods; a urea, a thiourea or a guanidine; ring is imidazole or 1,2,4-triazole or tetrazole; 4-{4-[4-(3,3-Dichloroprop-2-enyloxy)-2,6-dichlorophenoxy]butyl}-1-[4-(trifluoromethyl)phenyl]-1,2,4-triazolin-5-one; a 1,2,3,4-tetrazolin-5-one
08/21/2008US20080200511 Novel Compounds and Methods of Using the Same
08/21/2008US20080200467 alpha keto amides and alpha hydroxy amides; N-[3-(3-Morpholin-4-yl-propoxy)-phenyl]-2-oxo-2-(4-trifluoromethyl-phenyl)-acetamide; N-Adamantan-1-yl-2-(3-benzyloxyphenyl)-2-hydroxy-acetamide; hypertensive, cardiovascular, inflammatory, pulmonary, and diabetic-related diseases
08/21/2008US20080200445 Heterocyclic aspartyl protease inhibitors
08/21/2008US20080200335 Especially aphids and other difficult to control insects, arachnids and nematodes; applying to soils, crops, or seeds
08/21/2008US20080197084 Emulsion polymerization; oil industry
08/21/2008CA2678072A1 Functionally selective alpha2c adrenoreceptor agonists
08/21/2008CA2678036A1 Functionally selective alpha2c adrenoreceptor agonists
08/20/2008EP1958934A1 Tetrahydronaphthalenylamides, a process for their production and their use as anti-inflammatory agents
08/20/2008EP1958508A1 Phenoxymethyl imidazoline derivatives and their use as pesticides
08/20/2008EP1958507A1 Chemical compounds
08/20/2008EP1957465A2 Novel intermediates and their use
08/20/2008EP1957459A2 Iminopropene compound and use thereof
08/20/2008EP1756066B1 Tetrasubstituted imidazole derivatives as cannabinoid cb1 receptor modulators with a high cb1/cb2 receptor subtype selectivity
08/20/2008EP1249233B1 Npyy5 antagonists
08/20/2008CN101248062A C-fms kinase inhibitors
08/20/2008CN101248049A 咪唑类lxr调节剂 Imidazole lxr modifier
08/20/2008CN101248048A Imidazole based LXR modulators
08/20/2008CN101245019A Novel technique for synthesizing quaternary ammonium salt
08/20/2008CN100411624C Aqueous compositions containing metronidazole
08/19/2008US7414078 Oral general anesthetics and metabolitically resistant anticonvulsants
08/19/2008US7413727 Contrast agents
08/14/2008WO2008096351A1 Pharmaceutical compositions based on a microemulsion
08/14/2008US20080194834 solvents for producing cellulose esters; no sulfur and no halides; alkyl imidazolium carboxylate from reacting alkyl imidazolium formate and an anhydride via anion exchange;
08/14/2008US20080194551 Acetylene Derivatives
08/13/2008EP1954682A1 Novel 2-amino-imidazole-4-one compounds and their use in the manufacture of a medicament to be used in the treatment of cognitive impairment, alzheimer s disease, neurodegeneration and dementia
08/13/2008EP1954681A2 Compounds and methods for thiol-containing compound efflux and cancer treatment
08/13/2008EP1954680A1 Ionic liquids
08/13/2008EP1954674A1 New n-phenethylcarboxamide derivatives
08/13/2008EP1453501B1 N- aryl-n'-arylcycloalkyl-urea derivatives as mch antagonists for the treatment of obesity
08/13/2008EP1322309B1 High affinity small molecule c5a receptor modulators
08/13/2008CN101243053A N-acylic aminoacid derivatives, method for the production thereof, pharmacological composition and the use in the form of anti-allergic, anti-inflammatory and hypolipidemic agents
08/13/2008CN101243052A Helix 12 directed non-steroidal antiandrogens
08/13/2008CN101241774A A compound electrolyte material and its making method
08/13/2008CN101239951A 1-(2,3-dihydroxypropyl)-2-methyl-5-nitroimidazole compound and its preparation method and use
08/13/2008CN100411060C Fused-salt type oligomer electrolyte and its use
08/12/2008US7411098 Aldol condensation of citral with acetone and subsequent hydrogenation; using tetrahydrogeranylacetone for preparing phytol, isophytol, tocopherol and/or tocopherol derivatives
08/12/2008US7411072 e.g. 5-(10,11-Dihydro-dibenzo[a,d]cyclohepten-5-ylidenemethyl)-3H-benzooxazol-2-one; antiinflammatory, antidiabetic agent; electrolytes and water retention modulator; hypotensive, hypoglycemic agent; arrhythmias, myocardial fibrosis, osteoporosis, polyuria, polydipsia, Crohn's disease
08/12/2008US7411061 Method of synthesizing polynucleotides using ionic liquids
08/12/2008US7411004 Sulphones which modulate the action of gamma secretase
08/12/2008US7410999 Compounds, methods and compositions useful for the treatment of bovine viral diarrhea virus (BVDV) infection and hepatitis C virus (HCV) infection
08/12/2008US7410981 low toxicity; 2-[methyl[[(R)-2-[[[3-methyl-4-(2,2,2-trifluoroethoxy)-2-pyridyl]methyl]sulfinyl]-1H-benzimida zol-1-yl]carbonyl]amino]ethyl acetate; superior antiulcer activity, a gastric acid secretion inhibitory action, a mucosa-protecting action, an antiHelicobacter pylori action
08/12/2008US7410971 1,2-di(cyclic)substituted benzene compounds
08/12/2008US7410506 Dicationic bis-hydrazone compound, dye composition comprising at least one such compound, implementation process therefor and uses thereof
08/07/2008WO2008095069A2 High stability polyionic liquid salts
08/07/2008WO2008095064A2 High stability diionic liquid salts
08/07/2008WO2008093742A1 Process for production of binuclear metal complex
08/07/2008WO2008093272A2 Controlled release of active aldehydes and ketones from equilibrated dynamic mixtures
08/07/2008US20080188529 N1-(cyanomethyl)-N2-(2,2,2-trifluoro-1-phenylethyl)-L-leucinamide; antiarthritic agent; osteoporosis and other bone loss disorders
08/07/2008US20080188490 e.g. 1-(3-Chloro-phenylethynyl)-3-(3,4-difluoro-phenylamino)-cyclohexanol; metabotropic glutamate receptors modulator/antagonist;
08/07/2008US20080188489 Cell differentiation inducer
08/07/2008DE102008000237A1 Mixtures, useful e.g. as an inhibitor or retarder for the stabilization of polymerizable compound, preferably swellable hydrogel-forming polymers, comprises a phenol imidazole derivative and a polymerizable compound
08/07/2008DE102007004698A1 Verbindungen enthaltend Organofluorochlorophosphatanionen Compounds containing Organofluorochlorophosphatanionen
08/06/2008EP1951679A1 Imidazole compounds that modulate hsp90 activity
08/06/2008EP1638943B1 Novel imidazole derivatives, the production thereof, and the use of the same as a medicament
08/06/2008EP1439169B1 Difluoroalkene derivative, pest control agent containing the same, and intermediate therefor
08/06/2008EP1311475B1 Aminocyclohexane derivatives
08/06/2008EP1236712B1 Amidinophenylpyruvic acid derivative
08/06/2008CN100408566C Method for preparing analogue of carnosine
08/06/2008CN100408539C Vitamin d receptor modulators
08/05/2008US7407980 Therapeutic agents for treating central nervous system disorders, incotinence, sexual disorders, NASAL CONGESTION; ALPHA 1 ADRENERGIC AGONISTS; N-[4-(4,5-Dihydro-1H-imidazol-2-ylmethyl)-phenyl]-methanesulfonamide; chemical synthesis by cyclization
1 ... 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 ... 345